REG - IXICO plc - PDMR Transaction
RNS Number : 4793TIXICO plc25 March 202125 March 2021
IXICO plc
("IXICO" or the "Company")
Director/PDMR Dealing
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that Mark Warne, Non-Executive Director, today purchased 14,250 ordinary shares in the Company at an average price of 63 pence.
For further information please contact:
IXICO plc +44 20 3763 7499
Giulio Cerroni, Chief Executive Officer
Grant Nash, Chief Financial Officer
Cenkos Securities plc (Nominated adviser and sole broker) +44 20 7397 8900
Giles Balleny / Max Gould (Corporate Finance)
Michael F Johnson / Russell Kerr (Sales)
Walbrook PR Ltd
+44 (0)20 7933 8780
Paul McManus / Lianne Cawthorne /
IXICO@walbrookpr.com
Alice Woodings
The below makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1
Details of the person discharging managerial responsibilities/person closely associated
a.
Name
Mark Warne
2
Reason for notification
On market purchase
a.
Position/Status
Non-Executive Director
b.
Initial notification/
Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
IXICO plc
b.
LEI
2138005M1F59O6HWSA97
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the financial instrument, type of instrument
Identification CodeOrdinary shares of 1p each
ISIN: GB00BCLY7L40
b.
Nature of the transaction
Purchase of ordinary shares
c.
Price(s) and volume(s)
Price(s) per share
Volume(s)
£0.66
250 shares
£0.64
1500 shares
£0.65
1500 shares
£0.63
1500 shares
£0.61
1500 shares
£0.61
1500 shares
£0.63
1500 shares
£0.62
5000 shares
d.
Aggregated information
- Aggregated Volume
- Price
14,250 shares
£0.63
e.
Date of the transaction
24 March 2021
f.
Place of the transaction
London Stock Exchange, AIM Market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHKELBLFXLBBBK
Recent news on IXICO
See all newsREG - IXICO plc - Trading Update
AnnouncementREG - IXICO plc - Share option awards and PDMR Dealing
AnnouncementREG - IXICO plc - FDA Clearance of Alzheimer's Diagnostic Biomarker
AnnouncementREG - IXICO plc - Holding(s) in Company
AnnouncementREG - IXICO plc - Half-year Report
Announcement